Log In
BCIQ
Print this Print this
 

Vedrop, tocofersolan

  Manage Alerts
Collapse Summary General Information
Company Recordati S.p.A.
DescriptionWater-soluble vitamin E formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat chronic cholestasis in children; Treat vitamin E deficiency in children with chronic cholestasis or cystic fibrosis (CF); Treat vitamin E deficiency in children with chronic cholestasis or hereditary chronic cholestasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/16/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today